| Hepatitis B virus DNA contains a glucocorticoid-responsive element. R Tur-Kaspa, RD Burk, Y Shaul, DA Shafritz Proceedings of the National Academy of Sciences 83 (6), 1627-1631, 1986 | 523 | 1986 |
| Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. K Soares-Weiser, M Brezis, R Tur-Kaspa, L Leibovici The Cochrane database of systematic reviews, CD002907-CD002907, 2002 | 505* | 2002 |
| Cytokine gene polymorphisms in patients infected with hepatitis B virus Z Ben-Ari, E Mor, O Papo, B Kfir, J Sulkes, AR Tambur, R Tur-Kaspa, ... Official journal of the American College of Gastroenterology| ACG 98 (1 …, 2003 | 349 | 2003 |
| Relapsing hepatitis A review of 14 cases and literature survey M Glikson, E Galun, R Oren, R Tur-Kaspa, D Shouval Medicine 71 (1), 14-23, 1992 | 317 | 1992 |
| Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation E Mor, RT Kaspa, P Sheiner, M Schwartz Annals of internal medicine 129 (8), 643-653, 1998 | 303 | 1998 |
| Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes M Gal‐Tanamy, L Bachmetov, A Ravid, R Koren, A Erman, R Tur‐Kaspa, ... Hepatology 54 (5), 1570-1579, 2011 | 245 | 2011 |
| Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity L Bachmetov, M Gal‐Tanamy, A Shapira, M Vorobeychik, ... Journal of viral hepatitis 19 (2), e81-e88, 2012 | 231 | 2012 |
| The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer R Tur-Kaspa, Y Shaul, DD Moore, RD Burk, S Okret, L Poellinger, ... Virology 167 (2), 630-633, 1988 | 213 | 1988 |
| Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis LH Katz, A Fraser, A Gafter‐Gvili, L Leibovici, R Tur‐Kaspa Journal of viral hepatitis 15 (2), 89-102, 2008 | 187 | 2008 |
| Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells S Mitrani-Rosenbaum*, R Tsvieli, R Tur-Kaspa Journal of general virology 70 (8), 2227-2232, 1989 | 183 | 1989 |
| Use of electroporation to introduce biologically active foreign genes into primary rat hepatocytes R Tur-Kaspa, L Teicher, BJ Levine, AI Skoultchi, DA Shafritz Molecular and cellular biology 6 (2), 716-718, 1986 | 161 | 1986 |
| Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor Y Ilan, A Nagler, R Adler, R Tur-Kaspa, S Slavin, D Shouval Gastroenterology 104 (6), 1818-1821, 1993 | 158 | 1993 |
| The effects of dexamethasone on in vitro collagen gene expression. FR Weiner, MJ Czaja, DM Jefferson, MA Giambrone, R Tur-Kaspa, ... Journal of Biological Chemistry 262 (15), 6955-6958, 1987 | 154 | 1987 |
| Monoclonal antibody HCV‐AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study TD Schiano, M Charlton, Z Younossi, E Galun, T Pruett, R Tur‐Kaspa, ... Liver transplantation 12 (9), 1381-1389, 2006 | 148 | 2006 |
| Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials K Soares-Weiser, M Brezis, R Tur-Kaspa, M Paul, J Yahav, L Leibovici Scandinavian journal of gastroenterology 38 (2), 193-200, 2003 | 140 | 2003 |
| Lamivudine treatment for acute severe hepatitis B: a pilot study H Schmilovitz‐Weiss, Z Ben‐Ari, E Sikuler, E Zuckerman, W Sbeit, ... Liver International 24 (6), 547-551, 2004 | 132 | 2004 |
| Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity R Tur-Kaspa, A Klein, S Aharonson Hepatology 16 (6), 1338-1342, 1992 | 130 | 1992 |
| Role Of Cytokine Gene Polymorphism In Hepatitis C Recurrence And Allograft Rejection Among Liver Transplant Recipients 1 AR Tambur, JW Ortegel, Z Ben-Ari, E Shabtai, T Klein, R Michowiz, ... Transplantation 71 (10), 1475-1480, 2001 | 123 | 2001 |
| Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II Y Kitay-Cohen, A Amiel, N Hilzenrat, D Buskila, Y Ashur, M Fejgin, ... Blood, The Journal of the American Society of Hematology 96 (8), 2910-2912, 2000 | 121 | 2000 |
| Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta‐analysis LH Katz, M Paul, DG Guy, R Tur‐Kaspa Transplant Infectious Disease 12 (4), 292-308, 2010 | 115 | 2010 |
